Relay Therapeutics is seeking a patient-focused Medical Director to drive early clinical development in adult and pediatric rare diseases using our proprietary Dynamo™ protein-motion platform. Reporting to the SVP, Head of Clinical Development, you will lead clinical strategy from IND to proof-of-concept to approval, advancing multiple assets across rare disease therapeutic areas.

Your Role

• Lead clinical strategy and execution to rapidly establish proof-of-concept and accelerate development
• Develop regulatory-aligned clinical plans, identifying opportunities for breakthrough designation and accelerated approval
• Author and review key clinical documents (INDs, CTAs, regulatory responses) and oversee safety and pharmacovigilance.
• Integrate new scientific insights into development plans to optimize trial design and outcomes
• Build strong external collaborations with investigators, academic experts, and regulatory agencies

Your Background

• MD or MD/PhD with expertise in rare diseases (pediatric experience preferred)
• 1+ year of industry experience in early clinical development (small biotech experience a plus)
• Proven ability to design and execute innovative clinical trials and interpret complex data
• Strong leadership, cross-functional collaboration, and communication skills
• Passion for delivering life-changing therapies to patients

#ASM1

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our Dynamo platform integrates an array of leading-edge experimental and computational approaches to provide a differentiated understanding of protein structure and motion to drug these targets. We have built a world-class team of leading experts from each of these disciplines, and they are driven by a deep collaboration at every step of our drug discovery process.